CAS: 1441000-45-8
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | 4-Butoxy-N-{[4-(dimethylamino)oxan-4-yl]methyl}-3,5-dimethoxybenzamide REF: 3D-RHC00045CAS: 1441000-45-8 | Min. 95% | 229,00 €~2.029,00 € | Mo 14 Apr 25 |
 | Opiranserin REF: TM-T16399CAS: 1441000-45-8 | 98% | 907,00 €~2.375,00 € | Mo 21 Apr 25 |
![4-Butoxy-N-{[4-(dimethylamino)oxan-4-yl]methyl}-3,5-dimethoxybenzamide](https://static.cymitquimica.com/products/3D/thumb/RHC00045.jpg)
4-Butoxy-N-{[4-(dimethylamino)oxan-4-yl]methyl}-3,5-dimethoxybenzamide
CAS:1441000-45-8
4-Butoxy-N-[4-(dimethylamino)oxan-4-yl]methyl]-3,5-dimethoxybenzamide (BDMOB) is a molecule that has been shown to act as a serotonin receptor …
Formel:
C21H34N2O5
Reinheit:
Min. 95%
Molekulargewicht:
394.5 g/mol
Ref: 3D-RHC00045
| 50mg | 598,00 € | ||
| 500mg | 1.647,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Montag 14. April 2025
Opiranserin
CAS:1441000-45-8
Opiranserin is a development as an injectable agent for the treatment of postoperative pain.
Formel:
C21H34N2O5
Reinheit:
98%
Farbe und Form:
Solid
Molekulargewicht:
394.51
- Inhibitoren
- Neurowissenschaften
- 5-HT-Rezeptor
- GlyT
- Mehr Kategorien anzeigen
- GPCR/G-Protein
Ref: TM-T16399
| 25mg | 1.444,00 € | ||
| 50mg | 1.882,00 € | ||
| 100mg | 2.375,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Montag 21. April 2025
